切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2009, Vol. 03 ›› Issue (06) : 665 -669. doi: 10.3877/cma.j.issn.1674-0807.2009.06.011

综述

人绒毛膜促性腺激素与乳腺癌发生发展的关系
万舰1, 王颀1   
  1. 1.510010 广州,广州医学院附属广东省妇儿医院暨广东省妇幼保健院乳腺病中心
  • 收稿日期:2009-11-09 出版日期:2009-12-01

Study on the relationship between hCG and the development and progression of breast cancer

Jian WAN, Qi WANG   

  • Received:2009-11-09 Published:2009-12-01
引用本文:

万舰, 王颀. 人绒毛膜促性腺激素与乳腺癌发生发展的关系[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(06): 665-669.

Jian WAN, Qi WANG. Study on the relationship between hCG and the development and progression of breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2009, 03(06): 665-669.

[1]
Meduri G,Chamaux N,Spyratos F,et al.Luteinizing hormone receptor status and clinical,pathologic,and prognostic features in patients with breast carcinomas.Cancer,2003,97:1810-1816.
[2]
Russo J,Russo I H.Development of the human breast.Maturitas,2004,49:2-15.
[3]
Rao C V,Li X,Manna S K,et al.Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation.J Biol Chem,2004,279:25 503-25 510.
[4]
Alvarado M V,Alvarado N E,Russo J,et al.Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vivo.In Vitro,1994,30A:4-8.
[5]
Russo I H,Koszalka M,Russo J.Human chorionic gonadotropin and rat mammary cancer prevention.J Natl Cancer Inst,1990,82:1286-1289.
[6]
Russo I H,Koszalka M,Russo J.Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis.Br J Cancer,1991,64:481-484.
[7]
Russo J,Romero A L,Russo I H.Architectural pattern of the normal and cancerous breast under the influence of parity.Cancer Epidemiol Biomarkers Prev,1994,3:219-224.
[8]
Bernstein L,Hanisch R,Sullivan Halley J,et al.Treatment with human chorionic gonadotropin and risk of breast cancer.Cancer Epidemiol Biomarkers Prev,1995,4:437-440.
[9]
Janssens J P,Russo J,Russo I H,et al.Human chorionic gonadotropin(hCG)and prevention of breast cancer.Mol Cell Endocrinol,2007,269:93-98.
[10]
Guo S,Russo I H,Lareef M H,et al.Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells.Int J Oncol,2004,24:399-407.
[11]
Russo I H,Russo J.Hormonal approach to breast cancer prevention.J Cell Biochem,2000,34:S1-6.
[12]
Balogh G A,Russo I H,Spittle C,et al.Immune-surveillance and programmed cell death-related genes are significantly overexpressed in the normal breast epithelium of postmenopausal parous women.Int J Oncol,2007,31:303-312.
[13]
Russo J,Balogh G A,Russo I H.Full-term pregnancy induces a specific genomic signature in the human breast.Cancer Epidemiol Biomarkers Prev,2008,17:51-66.
[14]
Balogh G A,Russo J,Mailo D A,et al.The breast of parous women without cancer has a different genomic profile compared to those with cancer.Int J Oncol,2007,31:1165-1175.
[15]
Balogh G A,Heulings R,Mailo D A,et al.Genomic signature induced by pregnancy in the human breast.Int J Oncol,2006,28:399-410.
[16]
Russo J,Moral R,Balogh G A,et al.The protective role of pregnancy in breast cancer.Breast Cancer Res,2005,7:131-142.
[17]
Russo J,Balogh G,Russo I H.Breast cancer prevention.Climacteric,2007,10:47-53.
[18]
聂建云,金丛国,唐一吟,等.乳腺相关生理及病理因素对妇女乳腺癌患病的影响.中华乳腺病杂志:电子版,2008,2:526-532.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要